In silico approaches in organ toxicity hazard assessment: current status and future needs in predicting liver

Arianna Bassan1, Vinicius M Alves2, Alexander Amberg3

  • 1Innovatune srl, Via Giulio Zanon 130/D, 35129 Padova, Italy.

Insights

Predicting drug-induced liver injury (hepatotoxicity) is crucial in pharmaceutical development. This study reviews methods, emphasizing in silico approaches and proposing an integrated framework for better drug safety assessment.

Area of Science:

  • Toxicology
  • Pharmacology
  • Computational Chemistry

Background:

  • Hepatotoxicity is a major cause of drug failure in pharmaceutical R&D.
  • Current methods for assessing liver injury are often slow, costly, and lack sustainability.
  • There is a critical need for improved, faster, and more informative hepatotoxicity prediction methods.

Purpose of the Study:

  • To summarize the biological mechanisms of xenobiotic-induced hepatotoxicity.
  • To describe experimental and in silico approaches for predicting liver injury.
  • To propose a framework for integrating computational and experimental data.

Main Methods:

  • Review of biological mechanisms and experimental methods for hepatotoxicity assessment.
  • Analysis of in silico approaches, including toxicokinetics and dose considerations.
  • Development of a framework for integrating in silico and experimental data.

Main Results:

  • In silico methods are increasingly important for predicting hepatotoxicity.
  • Challenges include lack of standardized protocols and dose-independent models.
  • A case study demonstrates successful use of computational methods for regulatory questions.

Conclusions:

  • Integrated approaches combining in silico and experimental data are essential for accurate hepatotoxicity prediction.
  • Standardized protocols and dose-consideration in computational models are needed for wider adoption.
  • Improved prediction of liver injury will accelerate drug development and enhance patient safety.